Fabry disease: open trials in Belgium

• NCT06904261

  A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants

  Trial Treatment · Phase 3 · Amicus Therapeutics

  Universitair Ziekenhuis (Uz) Leuven, Leuven

  Registry updated 2026-10-22

• NCT00196742

  Fabry Disease Registry & Pregnancy Sub-registry

  Research · Genzyme, a Sanofi Company

  Antwerp · Antwerp · Brussels · Brussels · Brussels · Leuven · Liège · Seraing

  Registry updated 2026-10-14

• 2025-521244-38-00

  An Open-label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of 12-month Treatment with Migalastat in Pediatric Subjects (aged 2 to < 12 years) with Fabry Disease and Amenable GLA Variants

  Trial Treatment · Phase 3 · Amicus Therapeutics Inc.

  UZ Leuven, Leuven

  Registry updated 2026-04-24

All Fabry disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error